| For: | Khiani V, Kelly T, Shibli A, Jensen D, Mohanty SR. Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon α 2a therapy for chronic hepatitis C virus infection. World J Gastroenterol 2008; 14(2): 318-321 [PMID: 18186575 DOI: 10.3748/wjg.14.318] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i2/318.htm |
| Number | Citing Articles |
| 1 |
Kathryn R. Moss, Taylor S. Bopp, Anna E. Johnson, Ahmet Höke. New evidence for secondary axonal degeneration in demyelinating neuropathies. Neuroscience Letters 2021; 744 doi: 10.1016/j.neulet.2020.135595
|
| 2 |
Howard Chen. Muscle Channel Technique for Peripheral Sensory Neuropathy. Medical Acupuncture 2010; 22(1) doi: 10.1089/acu.2009.0714
|
| 3 |
Kensuke Shiga, Eijiroh Tanaka, Reina Isayama, Toshiki Mizuno, Kyoko Itoh, Masanori Nakagawa. Chronic Inflammatory Demyelinating Polyneuropathy Due to the Administration of Pegylated Interferon .ALPHA.-2b: A Neuropathology Case Report. Internal Medicine 2012; 51(2) doi: 10.2169/internalmedicine.51.6320
|
| 4 |
Isaak Quast, Flavio Cueni, Falk Nimmerjahn, Björn Tackenberg, Jan D. Lünemann. Deregulated Fcγ receptor expression in patients with CIDP. Neurology Neuroimmunology & Neuroinflammation 2015; 2(5) doi: 10.1212/NXI.0000000000000148
|
| 5 |
Jorge A Ortiz, Victor Araya, Marlene McGregory, Stephen F Penny, Eyob L Feyssa, Kashif Tufail, Ashaur Azhar, Mumtaz A Niazi. Guillain-Barre syndrome associated with peginterferon alfa-2a for chronic hepatitis C: A case report. World Journal of Hepatology 2010; 2(4): 162-166 doi: 10.4254/wjh.v2.i4.162
|
| 6 |
Viola Guardigni, Gabriele Fabbri, Anastasio Grilli, Carlo Contini. Successful antiviral treatment of chronic hepatitis C in patients with rare comorbidities. Two case-reports. Annals of Hepatology 2012; 11(3) doi: 10.1016/S1665-2681(19)30939-1
|
| 7 |
Chang Ying, Han Xue-mei, Gao Yao, Liu Song-yan. Chronic inflammatory demyelinating polyneuropathy following treatment with peglated interferon α-2a for chronic hepatitis C virus infection. Neurology India 2011; 59(1) doi: 10.4103/0028-3886.76885
|
| 8 |
Claudy Sarpong, Serena Bhaskerrao, Geraldine Kimberly Kra, Kyle Gabriel Bangayan, Kwesi Tuffour, Nathanael Matei. New insights into neurofilament and cytokine biomarkers: A narrative review. NeuroMarkers 2026; 3(2) doi: 10.1016/j.neumar.2025.100146
|
| 9 |
Jee-Eun Kim, Jae-Hyeok Heo, Hye-ok Kim, Sook-hee Song, Sang-Soon Park, Tai-Hwan Park, Jin-Young Ahn, Min-Ky Kim, Jae-Phil Choi. Neurological Complications during Treatment of Middle East Respiratory Syndrome. Journal of Clinical Neurology 2017; 13(3) doi: 10.3988/jcn.2017.13.3.227
|
| 10 |
Joerg-Patrick Stübgen. Interferon alpha and neuromuscular disorders. Journal of Neuroimmunology 2009; 207(1-2) doi: 10.1016/j.jneuroim.2008.12.008
|
| 11 |
Keiko Toyooka, Harutoshi Fujimura. Iatrogenic neuropathies. Current Opinion in Neurology 2009; 22(5) doi: 10.1097/WCO.0b013e32832fbc52
|
| 12 |
Richard AC Hughes, Jane Pritchard, Robert DM Hadden, Richard AC Hughes. Cochrane Database of Systematic Reviews. 2013; doi: 10.1002/14651858.CD008630.pub3
|
| 13 |
Luis del Carpio Orantes. Síndrome de Guillain y Barré variedad Miller Fisher asociado a hepatitis viral B. Neurología Argentina 2019; 11(1) doi: 10.1016/j.neuarg.2018.01.003
|
| 14 |
Kazuaki Nishio, Takeshi Konndo, Shunichi Okada, Machiko Enchi. Pericarditis and chronic inflammatory demyelinating polyneuropathy during therapy with pegylated interferon alfa-2a for chronic hepatitis C. World Journal of Hepatology 2010; 2(9): 358-361 doi: 10.4254/wjh.v2.i9.358
|
| 15 |
Monica Cesarini, Erika Angelucci, Tiziana Foglietta, Piero Vernia. Guillain–Barrè syndrome after treatment with human anti-tumor necrosis factorα (adalimumab) in a Crohn's disease patient: Case report and literature review. Journal of Crohn's and Colitis 2011; 5(6) doi: 10.1016/j.crohns.2011.06.010
|
| 16 |
Richard AC Hughes, Jane Pritchard, Robert DM Hadden, Richard AC Hughes. Cochrane Database of Systematic Reviews. 2011; doi: 10.1002/14651858.CD008630.pub2
|
| 17 |
Jonathan P. Congeni, Robert B. Kirkpatrick. Pegylated Interferon Induced Myasthenia Crisis—A Case Report. Journal of Clinical Neuromuscular Disease 2013; 14(3) doi: 10.1097/CND.0b013e318285257f
|
| 18 |
Jane Pritchard, Richard AC Hughes, Robert DM Hadden, Ruth Brassington. Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome. Cochrane Database of Systematic Reviews 2016; doi: 10.1002/14651858.CD008630.pub4
|
| 19 |
Alexandre Chlilek, Claire Roger, Laurent Muller, Marie-Josée Carles, Robin Stephan, Didier Laureillard, Jean-Philippe Lavigne, Jean-Yves Lefrant, Albert Sotto. Severe Guillain-Barré syndrome associated with chronic active hepatitis C and mixed cryoglobulinemia: a case report. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4278-7
|
| 20 |
Valerio Tonelli Enrico, William Anderst, Kevin M. Bell, J. Paulo Coelho, Jessa Darwin, Anthony Delitto, Carol M. Greco, Joon Y. Lee, Gina P. McKernan, Charity G. Patterson, Sara R. Piva, Michael J. Schneider, Lauren Wilcox, Nam V. Vo, Gwendolyn A. Sowa. Plasma Pro‐ and Anti‐Inflammatory Cytokines in an Observational Chronic Low Back Pain Cohort. JOR SPINE 2025; 8(3) doi: 10.1002/jsp2.70095
|
| 21 |
Fatime Nilüfer Yalçindağ, Cem Alay. Bell’s palsy during interferon alpha 2a treatment in a case with Behçet uveitis. F1000Research 2013; 2 doi: 10.12688/f1000research.2-245.v1
|
| 22 |
Bil Randerson Bassetti, Eduardo Sturzeneker Trés, Jovana Gobbi Marchesi Ciríaco, Lauro Ferreira Silva Pinto Neto. Polineuropatia desmielinizante inflamatória crônica pós-tratamento com interferon peguilado alfa 2b em um paciente co-infectado HIV/HCV: relato de caso. Revista da Sociedade Brasileira de Medicina Tropical 2010; 43(1) doi: 10.1590/S0037-86822010000100019
|
| 23 |
|
| 24 |
Joerg-Patrick Stübgen. Drug-induced dysimmune demyelinating neuropathies. Journal of the Neurological Sciences 2011; 307(1-2) doi: 10.1016/j.jns.2011.05.010
|
| 25 |
Benjamin R Wakerley, Nobuhiro Yuki. Infectious and noninfectious triggers in Guillain–Barré syndrome. Expert Review of Clinical Immunology 2013; 9(7) doi: 10.1586/1744666X.2013.811119
|
| 26 |
Sergio Ferrari, Sara Mariotto, Tiziana Cavallaro, Gianmaria Fabrizi, Salvatore Monaco. Acquired Neuromuscular Disorders. 2016; doi: 10.1007/978-3-319-29514-5_19
|
| 27 |
Stojan Perić, Luka Nikolić, Jelena Zlatar, Nikola Mitrović, Milica Dajević, Ivo Božović, Branislav Ralić, Ivana Basta, Aleksandra Kačar. Neurological complications of hepatitis C in Serbian population. Medicinska istrazivanja 2024; 57(3) doi: 10.5937/medi57-48168
|
| 28 |
Kato Verstrepen, Laure Baisier, Harald De Cauwer. Neurological manifestations of COVID-19, SARS and MERS. Acta Neurologica Belgica 2020; 120(5) doi: 10.1007/s13760-020-01412-4
|
| 29 |
Sergio Ferrari, Sara Mariotto, Tiziana Cavallaro, Gian Maria Fabrizi, Salvatore Monaco. Acquired Neuromuscular Disorders. 2022; doi: 10.1007/978-3-031-06731-0_19
|